Endocrine disruptors cost EU €157bn a year

Endocrine-disrupting chemicals linked to autism, lower IQ, infertility and obesity are costing Europe €157bn in annual health costs, a new study has found

by Rachel Salvidge
(photograph: monticello/123RF)
(photograph: monticello/123RF)

Sign in to continue

Sign in

Trouble signing in?

Reset password: Click here

Email: report@ends.co.uk

Call: 020 8267 8120

Register for
Free Trial

  • 14 day access to subscriber-only content



Prices on request

  • Full access to endsreport.com for 12 months
  • Monthly print issues
  • Clear and accessible guidance on relevant legislation
  • Integration with ENDS Compliance Manager helping you plan ahead and ensure compliance for your organisation
  • Individual or bespoke multi-user packages available

See all benefits